Delivery Order SPE2DB24D8003-SPE2DB25FJUXB
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,378.16 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division under the ECAT Generation V Program, which has a potential value of $999,999,999.00 and a performance period...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a medication used for the treatment of diabetes. The contract has a ceiling value of $1,873.80 and is a firm fixed price delivery order with a period of performance ending on May 22, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of Trulicity 3 mg/0.5 ml pen 0.5 ml, a diabetes management product, to support U.S. Armed Forces medical operations. The contract has a ceiling value of $1,312.08 and a period of performance through May 30, 2025. Dakota Drug, Inc. holds a significant single-award...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $2,749.16, is for the delivery of Trulicity 1.5 mg/0.5 ml pens. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT Generation V Program. This IDC allows the company to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $1,337.68, is for the delivery of Trulicity 3 mg/0.5 ml pens with a completion date of April 17, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to federal agencies, particularly the U.S. Armed Forces. The company holds a...
- The Defense Logistics Agency awarded a $4,246.94 delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Trulicity 0.75 mg/0.5 mL pens. This firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and carries no set-aside designation. The award represents a specific task order placed under Dakota Drug's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $1,312.08 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) worth $999,999,999.00 with the DLA Troop Support Medical under the ECAT Generation V Program, which allows the company to provide a wide range of pharmaceutical products,...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation. The $2,888.62 contract is for the provision of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has an ultimate completion date of September 12, 2024. Dakota Drug, Inc. has a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,392.45, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period ending on January 8, 2025. Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, providing a range of pharmaceutical and medical products to support U.S. Armed Forces...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of Trulicity 1.5 mg/0.5 ml pens. The $2,505.06 contract has a performance period through July 31, 2024 and does not have a set-aside designation. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows...
- SPE2DB24D8003Indefinite Delivery Contract
- SPE2DB24D8003-SPE2DB25FJUXBDelivery Order
The Defense Logistics Agency awarded a delivery order to Dakota Drug, Inc. for Trulicity 3 mg/0.5 mL pens with a firm fixed price ceiling value of $1,345.66. The delivery order, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents pharmaceutical procurement under the DLA's medical supply operations. Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, serves as a critical vendor in the federal marketplace, specializing in pharmaceutical products and medical supplies for U.S. Armed Forces healthcare operations. This award carries no set-aside designation and reflects the unrestricted competitive environment in which the company operates. This delivery order falls under Dakota Drug, Inc.'s broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DB24D8001), valued at $999,999,999.00 and running through December 31, 2025. The IDC, established through the DLA Troop Support Medical's ECAT Generation V Program, enables the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military medical facilities. Trulicity, a diabetes management medication, exemplifies the critical therapeutic categories the contractor delivers, including insulins, cardiovascular drugs, and other specialty pharmaceuticals essential to military healthcare delivery systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/28/25 |